Antidepressants in pregnancy (letter)

Editor, – Current research and information is essential in determining the need for pharmacotherapy of depression during pregnancy and postpartum (Aust Prescr 2007;30:125–7). Therapeutic Guidelines provides a framework for practitioners to address the decision of whether or not to prescribe a psychotropic drug. This includes the risks of prescribing as well as the risks of not prescribing. Another useful resource is the Therapeutic Advice and Information Service (TAIS), which is funded by the National Prescribing Service. By calling 1300 138 677, health professionals can obtain advice regarding individual patients in a timely manner. This information is provided by drug information pharmacists with access to current medical literature and clinical training to assist with questions relating to drug use during pregnancy and lactation.